Multiple sclerosis (MS) is a chronic inflammatory disorder that is thought to impact about 2.3 million people around the ...

Older men with MS who used androgen-modifying therapies showed unexpectedly sustained or increased disease activity in a ...

UC Riverside study may lead to new treatments for multiple sclerosis. Multiple sclerosis (MS) affects an estimated 2.3 ...

Mitochondrial abnormalities, or problems in cells' powerhouses, contribute to nerve cell death linked to motor control in MS, ...

Read full-text medical journal articles from Medscape's Multiple Sclerosis: Latest. News & Perspective Drugs & Diseases CME & Education Video Decision Point  Specialty: ...

Read full-text medical journal articles from Medscape's Multiple Sclerosis: Latest. X. No Results. No Results. For You News ... Eliminates Disease Activity A second-generation anti-CD40 therapy that ...

A study of twins reveals two gut bacteria linked to multiple sclerosis, offering new targets for future treatments.

Recent highlights in MS coverage focus on biomarkers, pregnancy, and neurodegeneration. Physician’s Weekly has compiled a ...

An engineered protein turns off the kind of immune cells most likely to damage tissue as part of Type-1 diabetes, hepatitis, ...

A blood test might predict when multiple sclerosis patients are about to suffer a relapse in their symptoms, a new study says ...

Tiziana (TLSA) is showing groundbreaking advancements in Alzheimer's & MS treatments with foralumab. Key trials & market insights reveal exciting opportunities. See more.